These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29197099)

  • 1. Identification of patterns of factors preceding severe or life-threatening asthma exacerbations in a nationwide study.
    Tanaka H; Nakatani E; Fukutomi Y; Sekiya K; Kaneda H; Iikura M; Yoshida M; Takahashi K; Tomii K; Nishikawa M; Kaneko N; Sugino Y; Shinkai M; Ueda T; Tanikawa Y; Shirai T; Hirabayashi M; Aoki T; Kato T; Iizuka K; Fujii M; Taniguchi M
    Allergy; 2018 May; 73(5):1110-1118. PubMed ID: 29197099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe or life-threatening asthma exacerbation: patient heterogeneity identified by cluster analysis.
    Sekiya K; Nakatani E; Fukutomi Y; Kaneda H; Iikura M; Yoshida M; Takahashi K; Tomii K; Nishikawa M; Kaneko N; Sugino Y; Shinkai M; Ueda T; Tanikawa Y; Shirai T; Hirabayashi M; Aoki T; Kato T; Iizuka K; Homma S; Taniguchi M; Tanaka H
    Clin Exp Allergy; 2016 Aug; 46(8):1043-55. PubMed ID: 27041475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization.
    Bengtson LGS; Yu Y; Wang W; Cao F; Hulbert EM; Wolbeck R; Elliott CA; Buikema AR
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1149-1159. PubMed ID: 29083972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
    Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
    Kew KM; Evans DJ; Allison DE; Boyter AC
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
    Anderson DE; Kew KM; Boyter AC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
    Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
    Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.
    Busch R; Han MK; Bowler RP; Dransfield MT; Wells JM; Regan EA; Hersh CP;
    BMC Pulm Med; 2016 Feb; 16():28. PubMed ID: 26861867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate-Severe Symptoms.
    Singh D; Oosterholt S; Pavord I; Garcia G; Abhijith Pg ; Della Pasqua O
    Adv Ther; 2023 Oct; 40(10):4606-4625. PubMed ID: 37589831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
    Oba Y; Keeney E; Ghatehorde N; Dias S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
    Wechsler ME; Yawn BP; Fuhlbrigge AL; Pace WD; Pencina MJ; Doros G; Kazani S; Raby BA; Lanzillotti J; Madison S; Israel E;
    JAMA; 2015 Oct; 314(16):1720-30. PubMed ID: 26505596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
    Lee LA; Bailes Z; Barnes N; Boulet LP; Edwards D; Fowler A; Hanania NA; Kerstjens HAM; Kerwin E; Nathan R; Oppenheimer J; Papi A; Pascoe S; Brusselle G; Peachey G; Sule N; Tabberer M; Pavord ID
    Lancet Respir Med; 2021 Jan; 9(1):69-84. PubMed ID: 32918892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.
    Craig SS; Dalziel SR; Powell CV; Graudins A; Babl FE; Lunny C
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012977. PubMed ID: 32767571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme.
    Bao W; Zhang Y; Hang J; Guo Y; Tang W; Yun C; Deng J; Jin M; Lai K; Yu H; Beekman M; Zhou X; Zhang M
    Ther Adv Respir Dis; 2022; 16():17534666221115054. PubMed ID: 36065527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming gaps in the management of asthma in older patients: new insights.
    Barua P; O'Mahony MS
    Drugs Aging; 2005; 22(12):1029-59. PubMed ID: 16363886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.